mRNA vaccines ‘protective’ in patients with IBD on biologics
A small but reassuring study shows every patient mounted an antibody response, researchers say
Patients with inflammatory bowel disease (IBD), even those receiving biologics, are able to mount a significant immune response after getting mRNA COVID-19 vaccines, a study shows.
In an analysis of data from 48 IBD patients, of whom 85% were taking biologics at the time of vaccination with either the Pfizer-BioNTech or Moderna vaccines, all had positive antibody responses.
